Over the past 12 months, 0 insiders at IGM Biosciences, Inc. filed 0 open-market SEC Form 4 transactions on IGMS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 25 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 4.4K | $1.27 | $6K |
| Jul 23, 25 | Mary Beth HarlerChief Executive Officer | SELL | 14.5K | $1.27 | $18K |
| Jul 23, 25 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 8.7K | $1.27 | $11K |
| Jun 16, 25 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 951 | $1.20 | $1K |
| Jun 16, 25 | Mary Beth HarlerChief Executive Officer | SELL | 1.5K | $1.20 | $2K |
| Jun 16, 25 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 1.5K | $1.20 | $2K |
| Jun 16, 25 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 486 | $1.20 | $583 |
| May 14, 25 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 1.9K | $1.12 | $2K |
| Mar 14, 25 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 4.5K | $1.23 | $6K |
| Mar 14, 25 | Mary Beth HarlerChief Executive Officer | SELL | 7.3K | $1.23 | $9K |
| Mar 14, 25 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 7.3K | $1.23 | $9K |
| Mar 14, 25 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 1.7K | $1.23 | $2K |
| Jan 15, 25 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 1.1K | $1.70 | $2K |
| Dec 16, 24 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 1.1K | $7.48 | $8K |
| Dec 16, 24 | Mary Beth HarlerChief Executive Officer | SELL | 1.7K | $7.48 | $13K |
| Dec 16, 24 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 1.7K | $7.48 | $13K |
| Dec 16, 24 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 539 | $7.48 | $4K |
| Sep 13, 24 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 925 | $11.54 | $11K |
| Sep 13, 24 | Mary Beth HarlerHead, Research & Autoimmunity | SELL | 1.5K | $11.54 | $17K |
| Sep 13, 24 | Bruce KeytCHIEF SCIENTIFIC OFFICER | SELL | 1.5K | $11.54 | $17K |
| Sep 13, 24 | Fred SchwarzerCEO AND PRESIDENT | SELL | 3.9K | $11.54 | $46K |
| Sep 13, 24 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 1.5K | $11.54 | $17K |
| Sep 13, 24 | Chris H TakimotoCHIEF MEDICAL OFFICER | SELL | 1.5K | $11.54 | $17K |
| Sep 13, 24 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 469 | $11.54 | $5K |
| Jul 25, 24 | Julie HambletonDirector | SELL | 15.1K | $14.00 | $212K |
| Jun 14, 24 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 977 | $7.58 | $7K |
| Jun 14, 24 | Mary Beth HarlerHead, Research & Autoimmunity | SELL | 1.6K | $7.58 | $12K |
| Jun 14, 24 | Bruce KeytCHIEF SCIENTIFIC OFFICER | SELL | 1.1K | $7.58 | $8K |
| Jun 14, 24 | Fred SchwarzerCEO AND PRESIDENT | SELL | 4.2K | $7.58 | $32K |
| Jun 14, 24 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 1.6K | $7.58 | $12K |
| Jun 14, 24 | Chris H TakimotoCHIEF MEDICAL OFFICER | SELL | 1.6K | $7.58 | $12K |
| Jun 14, 24 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 495 | $7.58 | $4K |
| Mar 28, 24 | Baker Bros. Advisors LpDirector,TenPercentOwner | BUY | 89.4K | $9.62 | $860K |
| Mar 27, 24 | Baker Bros. Advisors LpDirector,TenPercentOwner | BUY | 17.1K | $9.27 | $158K |
| Mar 26, 24 | Baker Bros. Advisors LpDirector,TenPercentOwner | BUY | 247.7K | $8.26 | $2.0M |
| Mar 14, 24 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 1.6K | $10.17 | $16K |
| Mar 14, 24 | Bruce KeytCHIEF SCIENTIFIC OFFICER | SELL | 1.8K | $10.17 | $19K |
| Mar 14, 24 | Fred SchwarzerCEO AND PRESIDENT | SELL | 4.2K | $10.17 | $43K |
| Mar 14, 24 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 2.5K | $10.17 | $26K |
| Mar 14, 24 | Chris H TakimotoCHIEF MEDICAL OFFICER | SELL | 2.5K | $10.17 | $26K |
| Mar 14, 24 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 464 | $10.17 | $5K |
| Mar 13, 24 | Lisa Lynn DeckerCHIEF BUSINESS OFFICER | SELL | 1.8K | $9.88 | $18K |
| Mar 13, 24 | Bruce KeytCHIEF SCIENTIFIC OFFICER | SELL | 2.1K | $9.88 | $21K |
| Mar 13, 24 | Fred SchwarzerCEO AND PRESIDENT | SELL | 4.8K | $9.88 | $47K |
| Mar 13, 24 | Misbah TahirCHIEF FINANCIAL OFFICER | SELL | 2.9K | $9.88 | $29K |
| Mar 13, 24 | Chris H TakimotoCHIEF MEDICAL OFFICER | SELL | 2.9K | $9.88 | $29K |
| Mar 13, 24 | Steven WeberPRINCIPAL ACCOUNTING OFFICER | SELL | 529 | $9.88 | $5K |
| Dec 15, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 214.0K | $6.60 | $1.4M |
| Dec 14, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 145.7K | $6.50 | $947K |
| Dec 13, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 71.2K | $5.99 | $427K |
Over the past 12 months, insiders at IGM Biosciences, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on IGMS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market IGMS insider purchase in our data was $2.0M by Baker Bros. Advisors Lp, Director,TenPercentOwner, filed on Mar 26, 24.
0 different insiders at IGM Biosciences, Inc. filed open-market SEC Form 4 transactions on IGMS over the last 12 months.
InsiderTape plots every IGMS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every IGM Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →